Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Thrombospondin 1 ELISA Kit (AC2815)
Cat.#: ASET-1404
Specifications
Description Human Thrombospondin 1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Thrombospondin 1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 2.39 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 22.5-360 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2388 Rabbit CRH ELISA Kit (AC3799) Quantitative inquiry ASET-1100 Human IL-6 ELISA Kit (AC2511) Quantitative inquiry ASET-1649 Rat Syndecan-1 ELISA Kit (AC3060) Quantitative inquiry ASET-1629 Mouse Ephrin A1 ELISA Kit (AC3040) Quantitative inquiry ASET-1295 Human NPFF2 Receptor ELISA Kit (AC2706) Quantitative inquiry ASET-1180 Human Agrin ELISA Kit (AC2591) Quantitative inquiry ASET-1715 Mouse CaMKII beta ELISA Kit (AC3126) Quantitative inquiry ASET-1792 Human PGRPS ELISA Kit (AC3203) Quantitative inquiry ASET-1708 Porcine Galectin-3 ELISA Kit (AC3119) Quantitative inquiry ASET-2483 Human Iba1 ELISA Kit (AC3894) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket